|
Oct 8
|
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
|
|
Oct 7
|
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
|
|
Oct 2
|
Recursion Pharmaceuticals (RXRX) Stock Dips While Market Gains: Key Facts
|
|
Oct 2
|
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
|
|
Sep 29
|
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
|
|
Sep 12
|
Recursion Pharmaceuticals, Inc. (RXRX): A Very Important AI Stock According to BlackRock
|
|
Sep 8
|
Recursion Pharmaceuticals, Inc. (RXRX): Among the Worst ARK Stocks According to Short Sellers
|
|
Aug 30
|
Is Recursion Pharmaceuticals a Warren Buffett Stock?
|
|
Aug 28
|
Recursion Pharmaceuticals Inc. (RXRX): Among The Best Medical AI Companies
|
|
Aug 1
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Jul 31
|
99.9% of Nvidia's $380 Million Investment Portfolio Has Been Put to Work in These 4 Artificial Intelligence (AI)-Inspired Stocks
|
|
Jul 29
|
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: Here's Why
|
|
Jul 27
|
Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip?
|
|
Jul 26
|
Wall Street Analysts Predict a 43.73% Upside in Recursion Pharmaceuticals (RXRX): Here's What You Should Know
|
|
Jun 8
|
Nvidia Owns These 4 Stocks. Here’s How They’re Doing.
|
|
Jun 7
|
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
|
|
Jun 3
|
Cathie Wood Owns These 2 AI Stocks. Should You?
|
|
Jun 2
|
Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
|
|
May 31
|
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
|
|
May 15
|
What's the Difference Between Biotech Stocks and TechBio Stocks?
|